StockFin.ai
NewsScreensInsightsPricing
/
Sign inTry Free
SF
New ChatNewsInsightsScreenerPricing
Sign In
NewsScreensChatSign In

Tools

Search Companies
News & Filings
Insights & Articles
FeaturesComing Soon
Pricing
Home › News › PPLPHARMA › Announcement

Piramal Pharma Ltd (PPLPHARMA) — Announcement | 29 September 2026

29 September 2026 · BSE Neutral
By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings
📢 Key Event
Trading window closure announced for designated persons
💡 Investor Takeaway
Routine procedural filing with no direct impact on shareholders.

Piramal Pharma announced that its trading window will close on October 1, 2026, and remain shut for 48 hours after the unaudited half‑year results for September 30, 2026 are released. The filing cites compliance with SEBI insider‑trading rules and the company’s code of conduct. ₹X crores is not specified, and no financial impact is disclosed.

📄 View Original Announcement (PDF)

📊 Stock Analysis — PPLPHARMA✨ Ask AI About This

About Piramal Pharma Ltd (PPLPHARMA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹27,485.68 CrROE: -3.8%ROCE: 1.7%

View full PPLPHARMA stock details →

📡 Get AI alerts when PPLPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track PPLPHARMA — Free

💡 Ask AI about this filing

"When will the unaudited half‑year results be declared?""What is the exact date of the board meeting to approve those results?""How does this trading restriction affect insider trading monitoring?"
Ask AI Free →

📊 More PPLPHARMA filings

  • 🔴 Announcement — 18 September 2026Piramal Pharma disclosed that an independent ESG rating agency, Niche99, assigned it an ESG score of...
  • 🔴 Announcement — 14 September 2026Piramal Pharma disclosed that the US FDA conducted a GMP inspection at its Morpeth, UK facility from...
  • 🔴 Announcement — 8 September 2026Piramal Pharma announced its schedule for upcoming institutional investor meetings in late September...
  • 🔴 Announcement — 3 September 2026Piramal Pharma disclosed that NSE Sustainability Ratings and Analytics assigned an ESG rating of 65 ...
  • 🔴 Announcement — 18 August 2026Piramal Pharma announced it completed the acquisition of an additional 40.67% stake in Yapan Bio Pri...
See all PPLPHARMA filings →

🔥 Also filed on 29 September 2026

ADANIENTAdani Enterprises LtdAnnouncementAPOLLOApollo Micro Systems LtdAnnouncementADANIPORTSAdani Ports & Special Economic Zone LtdAnnouncementADANIPOWERAdani Power LtdAnnouncementPFOCUSPrime Focus LtdAnnouncementMCXMulti Commodity Exchange of India LtdAnnouncement
View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when PPLPHARMA files new disclosures

Track PPLPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track PPLPHARMA — Free

Free account · 2 AI queries/day

© 2026 StockFin.ai is not a SEBI-registered advisor. For informational purposes only.

Data provided by CMOTS Internet Technologies Pvt Ltd

AboutPrivacy PolicyTerms of ServicePricing

Latest News

View all →
Mastek Ltd

Mastek schedules analyst meeting with Oyster Rock Capital

29 SeptMASTEK
Read more →
HDB Financial Services Ltd

Company Secretary and Head Legal resigns effective October 30, 2026

29 SeptHDBFS
Read more →
Transpek Industry Ltd

ICRA reaffirms Transpek Industry's credit ratings for bank facilities and fixed deposits

29 SeptTRANSPEK
Read more →
Global Capital Markets Ltd

Company confirmed non-applicability of Regulation 57(4) for Q3 2026

29 Sept530263
Read more →
Welspun Specialty Solutions Ltd

CARE reaffirms and upgrades Welspun Specialty Solutions' credit ratings following parent guarantee release

29 SeptWELSPLSOL
Read more →
Meesho Ltd

Allotment of 1,228,752 shares under ESOP 2024 Plan approved

29 SeptMEESHO
Read more →
Jackson Investments Ltd

Company confirmed non-applicability of non-convertible securities payment schedule for QE December 31, 2026

29 Sept538422
Read more →
BIL Vyapar Ltd

Committee of Creditors meeting scheduled for September 30, 2026

29 SeptBILVYAPAR
Read more →
GCM Capital Advisors Ltd

Non-applicability of Regulation 57(4) certificate for Q3 FY27

29 Sept538319
Read more →
Grand Foundry Ltd

SAR Televenture acquires 70.17% stake in Tikona Communication via open offer

29 SeptGFSTEELS
Read more →
Aadhaar Ventures India Ltd

Submission of 31st Annual Report for FY 2025-26 to BSE

29 Sept531611
Read more →
United Spirits Ltd

Nimish Shah resigns as CFO effective October 12, 2026

29 SeptUNITDSPR
Read more →
GCM Securities Ltd

No non-convertible securities issued in Q3 FY2027

29 Sept535431
Read more →
Platinum Industries Ltd

Subsidiary signs exclusive distribution deal for Korgludex in India

29 SeptPLATIND
Read more →
Share India Securities Ltd

CRISIL assigns A+/Stable rating to proposed NCDs

29 SeptSHAREINDIA
Read more →
Relicab Cable Manufacturing Ltd

Aryaman Capital acquired 203,700 shares via open market purchase

29 Sept539760
Read more →
Pine Labs Ltd

Pine Labs extends five-year technology partnership with Woolworths Group

29 SeptPINELABS
Read more →
TVS Srichakra Ltd

Show cause notice issued for alleged GST ITC mismatch

29 SeptTVSSRICHAK
Read more →
GCM Commodity & Derivatives Ltd

No non-convertible securities issued in Q3 FY27

29 Sept535917
Read more →
Syschem (India) Ltd

Company clarifies volume surge has no material cause

29 Sept531173
Read more →